http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022211775-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea845f982b72e03896327c3aec863591
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23Y2300-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2400-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23Y2300-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2400-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-745
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2022-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_537a684d063e6d7ad30bee8e7819c36b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41625c3f141032070c5fcd39b968401d
publicationDate 2022-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022211775-A1
titleOfInvention Food composition and pharmaceutical composition for inhibiting sjogren's syndrome each containing bifidobacterium pseudocatenulatum c-rapo (kctc13986bp) and bifidobacterium bifidum att (kctc13474bp)
abstract Disclosed are Bifidobacterium pseudocatenulatum C-RAPO (KCTC13986BP) and Bifidobacterium bifidum ATT (KCTC13474BP) strains that have the effects of inhibiting sialoadenitis, which is a symptom of the Sjogren's syndrome, and inhibiting a reduction in saliva flow rate. Based on this, these strains can be used for prevention or treatment of Sjogren's syndrome and can be developed into food, health food and pharmaceuticals.
priorityDate 2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617725-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226607037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226438275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5909

Total number of triples: 50.